Metabolomic Characterization of Fatty Acids in Patients With Coronary Artery Ectasias

Background: We used a targeted metabolomics approach to identify fatty acid (FA) metabolites that distinguished patients with coronary artery ectasia (CAE) from healthy Controls and patients with coronary artery disease (CAD).Materials and methods: Two hundred fifty-two human subjects were enrolled...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tianlong Liu, Yingying Sun, Hao Li, Haochen Xu, Ning Xiao, Xuliang Wang, Li Song, Congxia Bai, Hongyan Wen, Jing Ge, Yinhui Zhang, Weihua Song, Jingzhou Chen
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/01d4cd4f5f0d46a29dd1e1fc1fd525d4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:01d4cd4f5f0d46a29dd1e1fc1fd525d4
record_format dspace
spelling oai:doaj.org-article:01d4cd4f5f0d46a29dd1e1fc1fd525d42021-11-19T07:01:28ZMetabolomic Characterization of Fatty Acids in Patients With Coronary Artery Ectasias1664-042X10.3389/fphys.2021.770223https://doaj.org/article/01d4cd4f5f0d46a29dd1e1fc1fd525d42021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphys.2021.770223/fullhttps://doaj.org/toc/1664-042XBackground: We used a targeted metabolomics approach to identify fatty acid (FA) metabolites that distinguished patients with coronary artery ectasia (CAE) from healthy Controls and patients with coronary artery disease (CAD).Materials and methods: Two hundred fifty-two human subjects were enrolled in our study, such as patients with CAE, patients with CAD, and Controls. All the subjects were diagnosed by coronary angiography. Plasma metabolomic profiles of FAs were determined by an ultra-high-performance liquid chromatography coupled to triple quadrupole mass spectrometric (UPLC-QqQ-MS/MS).Results: Ninety-nine plasma metabolites were profiled in the discovery sets (n = 72), such as 35 metabolites of arachidonic acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), 10 FAs, and 54 phospholipids. Among these metabolites, 36 metabolites of AA, EPA, and DHA showed the largest difference between CAE and Controls or CAD. 12-hydroxyeicosatetraenoic acid (12-HETE), 17(S)-hydroxydocosahexaenoic acid (17-HDoHE), EPA, AA, and 5-HETE were defined as a biomarker panel in peripheral blood to distinguish CAE from CAD and Controls in a discovery set (n = 72) and a validation set (n = 180). This biomarker panel had a better diagnostic performance than metabolite alone in differentiating CAE from Controls and CAD. The areas under the ROC curve of the biomarker panel were 0.991 and 0.836 for CAE versus Controls and 1.00 and 0.904 for CAE versus CAD in the discovery and validation sets, respectively.Conclusions: Our findings revealed that the metabolic profiles of FAs in the plasma from patients with CAE can be distinguished from those of Controls and CAD. Differences in FAs metabolites may help to interpret pathological mechanisms of CAE.Tianlong LiuTianlong LiuYingying SunHao LiHaochen XuNing XiaoXuliang WangLi SongCongxia BaiHongyan WenJing GeYinhui ZhangWeihua SongJingzhou ChenFrontiers Media S.A.articleplasma metabolomic profilescoronary artery ectasiabiomarkerscoronary artery diseasefatty acid metabolitesPhysiologyQP1-981ENFrontiers in Physiology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic plasma metabolomic profiles
coronary artery ectasia
biomarkers
coronary artery disease
fatty acid metabolites
Physiology
QP1-981
spellingShingle plasma metabolomic profiles
coronary artery ectasia
biomarkers
coronary artery disease
fatty acid metabolites
Physiology
QP1-981
Tianlong Liu
Tianlong Liu
Yingying Sun
Hao Li
Haochen Xu
Ning Xiao
Xuliang Wang
Li Song
Congxia Bai
Hongyan Wen
Jing Ge
Yinhui Zhang
Weihua Song
Jingzhou Chen
Metabolomic Characterization of Fatty Acids in Patients With Coronary Artery Ectasias
description Background: We used a targeted metabolomics approach to identify fatty acid (FA) metabolites that distinguished patients with coronary artery ectasia (CAE) from healthy Controls and patients with coronary artery disease (CAD).Materials and methods: Two hundred fifty-two human subjects were enrolled in our study, such as patients with CAE, patients with CAD, and Controls. All the subjects were diagnosed by coronary angiography. Plasma metabolomic profiles of FAs were determined by an ultra-high-performance liquid chromatography coupled to triple quadrupole mass spectrometric (UPLC-QqQ-MS/MS).Results: Ninety-nine plasma metabolites were profiled in the discovery sets (n = 72), such as 35 metabolites of arachidonic acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), 10 FAs, and 54 phospholipids. Among these metabolites, 36 metabolites of AA, EPA, and DHA showed the largest difference between CAE and Controls or CAD. 12-hydroxyeicosatetraenoic acid (12-HETE), 17(S)-hydroxydocosahexaenoic acid (17-HDoHE), EPA, AA, and 5-HETE were defined as a biomarker panel in peripheral blood to distinguish CAE from CAD and Controls in a discovery set (n = 72) and a validation set (n = 180). This biomarker panel had a better diagnostic performance than metabolite alone in differentiating CAE from Controls and CAD. The areas under the ROC curve of the biomarker panel were 0.991 and 0.836 for CAE versus Controls and 1.00 and 0.904 for CAE versus CAD in the discovery and validation sets, respectively.Conclusions: Our findings revealed that the metabolic profiles of FAs in the plasma from patients with CAE can be distinguished from those of Controls and CAD. Differences in FAs metabolites may help to interpret pathological mechanisms of CAE.
format article
author Tianlong Liu
Tianlong Liu
Yingying Sun
Hao Li
Haochen Xu
Ning Xiao
Xuliang Wang
Li Song
Congxia Bai
Hongyan Wen
Jing Ge
Yinhui Zhang
Weihua Song
Jingzhou Chen
author_facet Tianlong Liu
Tianlong Liu
Yingying Sun
Hao Li
Haochen Xu
Ning Xiao
Xuliang Wang
Li Song
Congxia Bai
Hongyan Wen
Jing Ge
Yinhui Zhang
Weihua Song
Jingzhou Chen
author_sort Tianlong Liu
title Metabolomic Characterization of Fatty Acids in Patients With Coronary Artery Ectasias
title_short Metabolomic Characterization of Fatty Acids in Patients With Coronary Artery Ectasias
title_full Metabolomic Characterization of Fatty Acids in Patients With Coronary Artery Ectasias
title_fullStr Metabolomic Characterization of Fatty Acids in Patients With Coronary Artery Ectasias
title_full_unstemmed Metabolomic Characterization of Fatty Acids in Patients With Coronary Artery Ectasias
title_sort metabolomic characterization of fatty acids in patients with coronary artery ectasias
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/01d4cd4f5f0d46a29dd1e1fc1fd525d4
work_keys_str_mv AT tianlongliu metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
AT tianlongliu metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
AT yingyingsun metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
AT haoli metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
AT haochenxu metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
AT ningxiao metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
AT xuliangwang metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
AT lisong metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
AT congxiabai metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
AT hongyanwen metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
AT jingge metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
AT yinhuizhang metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
AT weihuasong metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
AT jingzhouchen metabolomiccharacterizationoffattyacidsinpatientswithcoronaryarteryectasias
_version_ 1718420294292471808